Anterior Lamina Cribrosa Surface Depth, Age, and Visual Field Sensitivity in the Portland Progression Project

Abstract

Purpose.: To assess the effect of age on spectral-domain optical coherence tomography (SDOCT)-detected lamina cribrosa depth while controlling for visual field (VF) status and retinal nerve fiber layer thickness (RNFLT) in 221 high-risk ocular hypertension and glaucoma patients enrolled in the Portland Progression Project.

Methods.: In this cross-sectional study, each participant underwent 870-nm SDOCT to obtain high-resolution radial B-scans centered on the optic nerve head (ONH) and a standardized ophthalmologic examination, including automated perimetry, on the same day. For each ONH, an anterior lamina cribrosa surface depth (ALCSD) parameter was generated as the average perpendicular distance from each anterior lamina cribrosa surface point relative to Bruch's membrane opening (BMO) reference plane within all 24 delineated B-scans. The relative effects of age, age-corrected VF status (mean deviation [MD]), and RNFLT on ALCSD were analyzed.

Results.: The mean age ± SD of participants was 64 ± 11 years (range, 33–90 years). The relationship between ALCSD and MD was age-dependent. ALCSD = 407.68 − 67.13 × MD − 0.08 × Age + 0.89 × MD × Age (MD, P = 0.001; MD × Age, P = 0.004). The relationship between ALCSD and RNFLT may also be age-dependent but did not achieve significance (interaction term, P = 0.067). ALCSD increased with worse VF status in younger eyes but not in older eyes. In older eyes, the anterior lamina was shallower than in younger eyes for the same VF status and RNFLT.

Conclusions.: These data are consistent with the concept that structure/structure and structure/function relationships change with age.

Introduction

Glaucoma is a progressive optic neuropathy that results in structural changes in the optic nerve head (ONH) and retinal nerve fiber layer (RNFL), as well as specific patterns of functional abnormality within the visual field (VF) that may eventually lead to severe visual impairment and blindness. ¹ A variety of data suggest that the optic nerve becomes more susceptible to progressive glaucomatous damage as it ages. In population-based studies, ^2–5 age is an independent risk factor for both the prevalence of the neuropathy ² and its progression, ^3–5 regardless of the stage of damage. However, the clinical appearance of glaucomatous structural alterations in the aged ONH has characteristic features, which, in their most recognizable forms, are described as “senile sclerotic cupping.” ^6,7 This is typically a shallow form of “cupping” with greater pallor accompanied by more extensive peripapillary atrophy at all stages of VF loss than the deeper forms of cupping that are most common in the eyes of children or young adults. ^6–13  

We have previously proposed that the “shallow” or “senile sclerotic” cupping of aged eyes is, in part, a manifestation of an increase in the structural stiffness of their ONH and peripapillary scleral connective tissues. ^14,15 The structural stiffness of a tissue is determined by the combination of its geometry (arrangement and amount) and its constituent material properties (whether they are compliant like rubber or stiff like steel). We have also predicted that age-related differences in ONH connective tissue structural stiffness ^16–25 should result in age-related differences in structure/structure (ONH/RNFL) and structure/function (ONH/VF) relationships ^14,15 : specifically, that the magnitude of laminar deformation associated with a given VF status should be greater in young eyes (or “compliant” eyes of all ages) than in old eyes (or “stiff” eyes of all ages). ^14,15 This concept is important because it may contribute to the emerging explanations for why the relationship between structural and functional changes might be specific to individual eyes and not necessarily predictable for all eyes. ²⁶  

ONH structural changes in glaucoma include connective tissue deformation ^27–37 and/or remodeling ^38,39 in addition to gliotic changes ⁴⁰ and retinal ganglion cell (RGC) axonal injury and loss. ¹⁵ Connective tissue deformation in glaucoma is more complicated than previously considered because of the dynamic interplay among the sclera, the scleral canal wall, and the lamina cribrosa ^41–43 and because these phenomena may change with age and disease stage. However, the following findings have been described in human and experimental glaucoma: peripapillary scleral bowing, ³⁵ scleral canal and neural canal expansion, ^30,33 posterior deformation, ^{27–29,31,37} initial thickening, ³⁷ subsequent thinning, ^27,28 and outward migration ³⁹ of the lamina cribrosa. 

Our specific hypothesis for this study was that, for a given level of IOP exposure, ONH structural changes in young eyes will be a manifestation of more posterior laminar deformation than RGC axon loss. Thus, ONH structural deformation in young eyes, characterized in terms of the depth of the anterior lamina cribrosa surface (ALCS) relative to Bruch's membrane opening, will likely be greater for a given amount of functional change and be associated with less RNFL loss than would the same amount of laminar deformation in older eyes. Stated differently, for a similar level of IOP exposure, the lamina will be less posteriorly deformed in older eyes than in younger eyes and for a given amount of laminar deformation will be associated with a greater amount of RNFL and functional loss. 

The potential to tease apart neural and connective tissue components of the glaucomatous ONH and retina has improved due to the advent of spectral-domain optical coherence tomography (SDOCT) imaging. ^44–48 In this cross-sectional study, we used SDOCT imaging to characterize anterior lamina cribrosa surface depth (ALCSD) ⁴⁶ relative to a Bruch's membrane opening (BMO) reference plane in 1 eye each of 221 high-risk ocular hypertension and glaucoma patients enrolled in the Portland Progression Project. We then assessed the effect of age on ALCSD while controlling for IOP and 2 surrogates for stage of glaucomatous damage: VF status and RNFL thickness (RNFLT). 

Subjects and Methods

Data for this study were obtained from the Portland Progression Project (P3 study), ⁴⁹ a National Institutes of Health (NIH)-funded longitudinal study of progression in participants with high-risk ocular hypertension and glaucoma based at the Devers Eye Institute in Portland, Oregon. The protocol was approved by the Legacy Health Institutional Review Board. The study adheres to the tenets of the Declaration of Helsinki and complies with the Health Insurance Portability and Accountability Act of 1996. All participants provided written informed consent after having the risks and benefits of participation explained to them. 

At study entry participants had either early glaucoma with VF loss less severe than −6 dB for mean deviation (MD) or ocular hypertension (untreated IOP greater than 22 mm Hg) plus 1 or more risk factors for the presence or progression to glaucoma as determined by their clinician. Risk factors for the presence or progression to glaucoma included age > 70 years, systemic hypertension, migraine, diet-controlled diabetes, peripheral vasospasm, African ancestry, self-reported family history of glaucoma, and suspicious ONH appearance (cup-to-disc ratio asymmetry > 0.2, neuroretinal rim notching, or narrowing or disc hemorrhage). All participants also met the following criteria for both eyes: best corrected visual acuity of 20/40 or better and spectacle refraction less than ±5.00-diopter (D) sphere and less than ±2.00-D cylinder. Potential participants were excluded if they had any previous or current ocular or neurologic disease likely to affect the VF and previous ocular surgery (except uncomplicated cataract surgery). 

SDOCT ONH imaging was introduced into the P3 imaging protocol in 2009, at which point a subset of subjects had progressed to more advanced stages of VF loss. For the current study, only SDOCT data from the baseline SDOCT ONH imaging session or the nearest session in which acceptable VF testing was available were included. In addition to SDOCT ONH and RNFL imaging, all participants underwent standard automated perimetry and IOP measurement by Goldmann applanation tonometry on the same day. 

SDOCT and Visual Field Data Acquisition

Data from 1 eye of each participant were included. For each participant, the eye with the best qualitative SDOCT laminar visualization was chosen. In those participants in whom SDOCT laminar visualization was qualitatively similar in both eyes, 1 eye was randomly selected. 

Standard automated perimetry VF testing was performed using a Humphrey Field Analyzer II (Carl Zeiss, Meditec, Inc., Dublin, CA) using the 24-2 testing pattern and conventional test procedures. All tests used the Swedish interactive thresholding algorithm (SITA)-standard threshold strategy. ⁵⁰ An optimal lens correction was placed before the tested eye, and the fellow eye was occluded with a white plastic eye patch. All participants had previous experience with VF testing prior to entering the study, and most had undergone multiple VF tests prior to the first session, in which SDOCT ONH imaging was also performed. Only reliable VFs were included, defined as ≤30% false negatives and fixation loss and ≤20% false positives. If fixation loss was >30%, then a note from the technician confirming that fixation was observed to be stable throughout the test could override the blind spot monitor report, as fixation losses can be erroneously reported when the perimeter's initial mapping of the blind spot is inaccurate. The MD index was used to characterize the functional status. 

SDOCT imaging was performed using a standard Spectralis unit (Heidelberg Engineering, GmbH, Heidelberg, Germany) with an 870-nm source. A radial scanning pattern visually centered on the ONH by the technician was used to obtain 48 high-resolution radial B-scans over a 15° area (768 A-scans per B-scan), as seen in Figure 1. The device's eye-tracking capability was used during image acquisition to enable B-scan sweep averaging (n = 9) in real time to reduce speckle noise. ⁵¹ All acquired SDOCT scans had a quality score better than 15. 

Figure 1

 

Settings were 15° scan, 48 radial B-scans, 768 A-scans/B-scan, and each B-scan was the average of n = 9 repetitions.(A) IR image shows 48 radial B-scan pattern overlay. (B) Representative B-scan as described in the legend to (A). (C) Delineated B-scan shown in (B). Light blue lines indicate the ILM, turquoise lines the posterior surface of the RNFL, orange lines are the posterior surface of the BM/RPE complex, red points are the BMO, and purple points are the ALCS. (D) Point cloud of delineated points from the 24 radial B-scans that were delineated as a subset (see Subjects and Methods).

SDOCT Image Delineation

Our strategy for SDOCT ONH image delineation has been described in a series of previous reports. ^46,47,52 Raw SDOCT volumes were exported into our custom-made “multiview” three-dimensional (3D) visualization and delineation software based on the Visualization Toolkit (VTK, Clifton Park, NY). ONH and peripapillary RNFL landmarks were then manually delineated within every second radial B-scan (24 total) of each SDOCT volume (Fig. 1). Two operators (RR and CH), who were masked to all other participant information, performed all of the delineations. Delineated landmarks (Fig. 1) included the internal limiting membrane (ILM); the posterior surface of the RNFL and posterior surface of the Bruch's membrane/retinal pigment epithelium (BM/RPE) complex; the BMO (defined as the innermost termination of the SDOCT-detected BM/RPE on either side of neural canal); and the ALCS. 

In the case of the ILM, RNFL, and BM/RPE complex, each surface was delineated using discrete points connected by a Bézier curve. Within each radial B-scan, delineated points for each landmark were finely adjusted so that the fitted Bézier curve most closely matched the anatomy. The strategy for delineating the ALCS was based on our previous direct comparisons between SDOCT B-scans and matched histologic sections obtained from a normal non-human primate eye, ⁴⁷ as well as our previous publications on SDOCT longitudinal change detection ⁴⁶ and enhanced depth versus standard SDOCT imaging. ⁵² Within each B-scan, we identified the ALCS as being the most anterior point where a horizontally oriented, high-intensity signal below the disc surface intersected the high-intensity vertical striations we previously identified to be the prelaminar glial columns (Fig. 2). It is important to note that the ability to see the ALCS was diminished in regions where there was pronounced shadowing from overlying retinal vessels. For this reason, the ALCS was delineated using discrete marks rather than using continuous Bézier curves, and the delineators could use any number of marks, at their discretion, to delineate the ALCS. For each SDOCT volume, the best fitting spline through the 48 delineated BMO points was used to define the reference plane (BMO reference plane). ^46,47,52,53 The following parameters were then calculated as single values for each SDOCT scan based on the BMO best-fit ellipse: BMO area, BMO major (maximum diameter), and BMO minor (minimum diameter). 

Figure 2

 

Method of ALCS point filtration and sector quantification are shown. (A) The ALCS points (black glyphs) are projected onto the plane (BMO reference plane) of a BMO B-spline (red circle line) best fitted to the BMO delineations. (B) The BMO B-spline is scaled into the unit circle space and subdivided into 72 sectors of equal area. (C) Sectors where 2 or more ALCS-delineated points are present in each volume are maintained for analysis. Sectors where there are fewer than 2 delineated points (black glyphs highlighted by red arrows) in each volume are filtered out of the analysis. (D) The circle is transformed back to its original space, with the filtered ALCS points removed.

Quantification of the Extent of ALCS Delineation

We previously described our method for quantifying the extent of ALCS delineation (MatLab; MathWorks, Natick, MA) (Fig. 2). ^46,47,52 All delineated BMO and ALCS points were projected onto the BMO reference plane. The projected BMO points were connected by a B-spline. ^33,52,53 The BMO B-spline, along with all of the contained projected ALCS points were converted to unit circle space and divided into a grid of 72 equal area sectors by using concentric rings and radial lines (Fig. 2). BMO sectors containing 2 or more projected ALCS points were considered delineated and included in the analysis. BMO sectors containing less than 2 projected ALCS points were excluded. After this point-filtration step, the unit circle space was converted back to the original projected BMO point B-spline configuration (Fig. 2). 

ONH and RNFL Parameterization in Each SDOCT Volume

The ALCSD parameter was defined as the average perpendicular distance from each ALCS point relative to the BMO reference plane included within the 24 delineated B-scans of each ONH (Fig. 3). However, the delineated ALCS points were “weighted” so that points in the peripheral lamina contributed greater weight to the mean than those in the central portion of the lamina. ⁴⁶ This was done because the points in the peripheral part of the lamina represent a “wider” arc than those toward the BMO centroid (i.e., the area of the ALCS wedge represented by a given point increases with the distance that point is from the BMO centroid). The weightings for each delineated point were thus proportional to the distance from the BMO centroid. SDOCT RNFLT was calculated at an eccentricity of 1700 μm (3.4-mm diameter) from the BMO centroid as previously described ^46,52,54 and reported as the average minimum distance between the ILM and the posterior surface of the RNFL at 1700-μm eccentricity from the BMO centroid within the 24 delineated B-scans of each ONH (Fig. 4). 

Figure 3

 

ALCSD measurement is shown. (A) ALCSD (yellow arrows) was quantified as the perpendicular distance from each delineated ALCS point to BMO reference plane (seen in cross-section as a red line) that met the criteria for inclusion (Fig. 2). (B) Mean ALCSD was the average of all ALCSD measurements (yellow) in 3D space for the 24 radial B-scans that were delineated for each ONH. The ILM (light blue) and outer RNFL (turquoise) are also shown.

Figure 4

 

RNFLT measurement is shown (pink band). (A) RNFLT was measured on either side of the canal at ILM points that are 1700 μm (3.4-mm diameter) from the centroid of the 48 delineated BMO points (the BMO centroid). The perpendicular projection of the BMO centroid is shown as the central white vertical dotted line. RNFLT at each ILM point is the minimum distance (pink arrow) between the ILM and the posterior RNFL boundary (turquoise B-spline line). (B) 3D representation of interpolated RNFLT (pink band) is based on the 24 delineated B-scans.

To increase the likelihood that we were making comparisons between the most posterior portions of the ALCS within all study eyes, we calculated 3 additional ALCSD parameters for each study eye. ALCSD_max1 was defined as the mean ALCSD value from the top 10% of all ALCSD values; ALCSD_max2 was defined as the mean ALCSD value from those BMO sectors containing the top 5% of all ALCSD values; and ALCSD_central was defined as the mean ALCSD values from the center-most third of the projected ALCS sectors. 

Statistical Analysis

Statistical analyses were performed using the R software (R Foundation for Statistical Computing, Vienna, Austria). Clinical parameters and general ONH/RNFL outcome parameters (Table) are means ± standard deviations. Univariate least-squares regression models were formed to predict ALCSD from age and ALCSD from IOP. Multivariate models were constructed to assess the effects of age, MD, and their interactions on ALCSD, ALCSD_max1, ALCSD_max2, and ALCSD_central. 

Table

 

Characteristics of the 221 Participants and the 221 Eyes in the Study

Characteristic	Mean ± Standard Deviation	Range
Age, y	64.3 ± 11.0	33.0–90.0
Intraocular pressure, mm Hg	17.4 ± 3.5	5.0–29.0
Mean deviation, dB	−0.69 ± 2.94	−16.53–3.29
ALCSD, μm	405 ± 119	178–835
SDOCT RNFLT, μm	89 ± 16	36–122
BMO area, mm2	1.85 ± 0.43	1.03–3.20
BMO major, μm	1619 ± 186	1173–2169
BMO minor, μm	1442 ± 173	1083–1929

 ALCSD, anterior lamina cribrosa surface depth; BMO, Bruch's membrane opening; RNFLT, retinal nerve fiber layer thickness; SDOCT, spectral-domain optical coherence tomography.

Univariate least-squares regression models were also formed to predict RNFLT from age and ALCSD from RNFLT. Multivariate models were constructed to assess the effects of age and RNFLT, and their interactions on ALCSD. Finally, the relationships using each of the 3 alternative definitions of ALCSD with RNFLT and age were assessed with univariate least-squares regression models and multivariate models. 

Results

This cross-sectional study assessed 227 eyes of 227 participants. Six eyes were excluded from analysis because of poor ALCS visibility. Therefore a total of 221 of 227 eyes (97%) were included for analysis, ranging in age from 33 to 90 years old (mean ± SD age, 64 ± 11 years). Almost all participants were Caucasian (212 of 221, 96%) with 91 (41%) being male. The right eye was selected for 112 (51%) individuals. The demographics and clinical characteristics of the participants, together with their ALCSD and RNFLT data are summarized in the Table. Mean ± SD ALCSD was 405 ± 119 μm (range, 178–835 μm). Mean RNFLT was 89 ± 16 μm (range, 36–122 μm). 

The mean number of delineated ALCS sectors for an eye (from a total of 72 [Fig. 2]) was 40 ± 13 (range, 13–72). Among the central 24 sectors, the mean ± SD number of delineated ALCS sectors was 20 ± 5 (range, 3–24). The percentage of ALCS projected area delineated was 56 ± 18% (range, 18%–100%). While the extent of nondelineated ALCS projected area was variable among participants, in most eyes it generally corresponded to the location of the central retinal vasculature. 

Figures 5 and 6 show that the association between ALCSD and MD is age-dependent. The regression equation for ALCSD was ALCSD = 407.68 − 67.13 × MD − 0.08 × Age + 0.89 × MD × Age. Whereas both the MD (P = 0.001) and the MD × Age (P = 0.004) terms achieved significance, the Age term did not (P = 0.921). There was no significant univariate association between ALCSD and age (P = 0.504) or ALCSD and IOP (P = 0.222). These results indicate the following relationships within the data: first, ALCSD tends to be greater (deeper) with worse VF status (i.e., when MD is more negative) because the coefficient associated with the MD term (−67.13) makes the product (−67.13 × MD) progressively more positive. Second, this effect is lessened as age increases because the (0.89 × MD × Age) term becomes more negative with advancing age, reducing (shallowing) the ALCSD. 

Figure 5

 

The relationship between ALCSD and age is shown, with points shaded according to their VF MD. The regression equation for ALCSD was: ALCSD = 407.68 − 67.13 × MD − 0.08 × Age + 0.89 × MD × Age (MD, P = 0.001; age, P = 0.921; MD × age, P = 0.004). Each point is shaded by the value of the MD, with the darkest being the lowest MD values (continuous scale to the right). By our convention, ALCSD as a parameter becomes greater as the distance between the ALCS and the BMO reference plane increases (Fig. 3). Two regression lines are shown, based on the equation given above: the relationship between ALCSD and age for MD = 0 dB (solid gray line), and the relationship for MD = −10 dB (dashed gray line). For a given amount of damage (or worse MD), the ALCS is deeper in younger eyes than in older eyes. Note that most cases with worse VF status (darker colored dots) are located in the upper right portion of the distribution, that is, in older eyes with shallower ALCSD.

Figure 6

 

The relationship between ALCSD and VF MD is shown, with points shaded according to their age. Each point is shaded by age, with the darkest being the oldest age values (continuous scale to the right). Two regression lines are shown, based on the same equation as given in Figure 5: the relationship between ALCSD and MD at age 55 (solid gray line) and the relationship at age 75 (dashed gray line). For younger subjects, the ALCS is deeper in more damaged eyes. For older subjects, the surface depth is unrelated to the amount of damage.

Figure 5 plots ALCSD against age, with points shaded according to their MD (darker points indicate worse MD). Two examples of regression lines are shown based on the equation given above. The solid gray line (Fig. 5) represents the relationship between ALCSD and age when MD = 0 dB. The dashed gray line (Fig. 5) represents the same relationship when MD = −10 dB. These examples suggest that among eyes with no detectable VF loss, there are no significant differences between the ALCSD of young and those of old eyes. However, among eyes with a given amount of VF loss (in this case −10 dB), the anterior lamina surface is deeper in younger eyes than in older eyes. Note that most cases with worse VF status (darker shaded symbols) are located to the right (older eyes) and toward the top (eyes with relatively shallow lamina cribrosa) of the scatterplot. 

Figure 6 plots ALCSD against MD, with points shaded according to their age (darker symbols indicate older subjects). In this case, the two example lines (Fig. 6) show the relationship between ALCSD and MD at age 55 (Fig. 6, solid gray line) and age 75 (Fig. 6, dashed gray line). Note that in older eyes (here, age 75) ALCSD is unrelated to the VF status. However, among younger eyes (here, age 55), ALCSD is deeper when the status of the VF is worse. 

Univariate correlations among 3 additional ALCSD parameters that were designed to more fairly compare laminar position among the study eyes (ALCSD_max1, ALCSD_max2, and ALCSD_central) and the 3 outcome parameters (age, IOP, and MD) were similar to those reported for ALCSD. Multivariate relationships among the 3 additional ALCSD parameters and MD were also age-dependent. The interaction term MD × Age was consistently significant, with P = 0.007, P = 0.007, and P = 0.004, respectively. 

There was also a significant association between RNFLT and age such that RNFLT = 112.26 − 0.37 × Age (P < 0.001). There was no significant univariate association between RNFLT and ALCSD (P = 0.225) or between RNFLT and IOP (P = 0.226). If RNFLT was used as an indicator of “disease stage” instead of MD, then the regression equation describing ALCSD was ALCSD = 1021.51 − 6.22 × RNFLT − 8.38 × Age + 0.08 × RNFLT × Age (RNFLT, P = 0.040; Age, P = 0.047; RNFLT × Age, P = 0.067). ALCSD was greater in eyes with a thinner RNFL, and this effect was again reduced in older than in younger eyes, as it was for MD. Moreover, the relationships using each of the 3 alternative definitions of ALCSD relative to RNFLT appeared to be similar, and the interaction term (RNFLT × Age) for each definition achieved a similar level of significance (ALCSD_max1, P = 0.081; ALCSD_max2, P = 0.074; ALCSD_central, P = 0.085). 

Discussion

Our findings suggest that older eyes have a lamina that is shallower than younger eyes at a given level of VF loss and that this age-related difference increases with advancing disease severity (i.e., for each dB of VF damage). These findings were consistent across a variety of laminar depth parameters and were also present when RNFLT rather than MD was used as a measure of “disease stage.” 

Rho et al. ⁵⁵ reported age-related differences in laminar displacement in 8 of 12 clock-hour positions in 26 eyes of 26 primary open-angle glaucoma (POAG) patients but interestingly found no age-related differences in laminar displacement among 52 eyes of 52 normal tension glaucoma patients. Similar to our study, they adjusted their comparisons for severity of VF damage and IOP at presentation. Unlike our study, they found direct (negative) correlations between age and laminar position in the POAG subgroup and hypothesized that the low levels of IOP at which normal tension glaucoma occurs and progresses did not allow for age-related differences in laminar stiffness to be clinically manifested within the normal tension glaucoma group. 

The hypothesis that the structural stiffness of the ONH and peripapillary scleral connective tissues contribute to an individual eye's structure/function association is important because it leads to predictions that can be tested longitudinally in young eyes (or compliant eyes of all ages) and in old eyes (or stiff eyes of all ages). For example, in eyes that have similar levels of detected IOP exposure, is ONH structural progression more likely to precede RNFL and/or VF progression in compliant as compared with stiff eyes? Conversely, is detectable VF and/or RNFL change more likely to precede detectable ONH structural change in stiff versus compliant eyes? 

If ONH structure/function relationships are eye-specific, it will be due in part to the fact that ONH structural change includes multiple components, each of which may contribute variably to RGC axon damage and eventual functional loss. Reversible conformational change or deformation of the neural and connective tissues that does not harm the adjacent RGC axons may occur at all levels of IOP depending upon the compliance of the ONH tissues. ^56,57 Connective tissue remodeling ^38,39 in response to IOP- and non-IOP-related stimuli should result in permanent (irreversible) change and may protect or insult the adjacent axons. ¹⁵ RGC axon cytoarchitectural disruption ^58,59 may be reversible and precede RGC axon damage and loss. Finally, RGC axon loss, by whatever mechanism, may be related to functional loss in a variable manner, depending upon the test. ⁶⁰  

It has been suggested that structure/function relationships in glaucoma change with age. ^26,61 Our data additionally suggest that if there are age-related differences in structure/function associations, there may be multiple mechanisms by which these occur. 

Our study has the following limitations. First, the fact that we found no significant univariate association between IOP and ALCSD or RNFLT may be due to the fact that our IOP characterization relied on a single IOP measurement during regular clinic hours performed closest to the SDOCT scan date. IOP is a dynamic parameter with distinct circadian rhythms that vary among individuals. There is evidence that single IOP measurements during regular clinic hours fail to reflect the true range of an individual's IOP. ⁶² Studies that evaluate 24-hour IOP in glaucoma patients have found that two-thirds of patients exhibit their highest IOP values outside regular clinic hours, most frequently during nocturnal/sleep period. ^63–65  

In addition to the lack of a complete IOP characterization at the time it was measured, the IOP risk factor is likely to be most important to the hypotheses we tested is some measure of the cumulative IOP insult that occurred in each eye over the full period in which the structural and functional changes we characterized had occurred. Such a characterization is not possible for several reasons. It would require knowing the point at which the neuropathy started in each study eye; accurate telemetric characterization of IOP magnitude and fluctuation over the entire course of the neuropathy; and knowing the relative contributions of IOP magnitude and IOP fluctuation to IOP insult. 

Second, the measure of functional VF status used (MD) was corrected for age and may therefore be a good indicator of the amount of glaucomatous damage (given the strict exclusion criteria). However our measurements of ALCSD and RNFLT were not corrected for age and thus only indirectly reflect damage. Prospective longitudinal studies are required that directly measure the magnitude of ALCSD, RNFLT, and MD change over time. 

Third, this study used standard SDOCT rather than enhanced depth imaging, which might have provided a more accurate characterization of ALCSD. ^48,66,67 Our previous study ⁴⁷ provided histologic verification of standard SDOCT ALCS delineation. In the present study, using standard SDOCT, the percentage of ALCS sectors that achieved our criteria for visualization ranged from 18% to 100% (median, 54%) with most eyes achieving greater than 50% visualization. 

Axial length was not measured in our study participants. Its use might have allowed us to more accurately correct for eye-specific transverse magnification. As a result, the location of the RNFLT measurements in each eye might not have been as consistent among all study eyes, although the magnitude of this effect should be limited by the range of accepted refractive errors. Because SDOCT measurements in the z-axis should not require magnification correction, our measurements of ALCSD and RNFLT should have been only minimally affected both because we excluded eyes with spectacle refraction equal to or greater than ±5.00-D sphere and equal to or greater than ±2.00-D cylinder, and only the transverse component of our ALCSD and RNFLT measurements would require correction. 

Finally, this is a cross-sectional study that detected an effect of age which we hypothesized to be related to laminar stiffness. However, the contribution of age and ONH structural stiffness to the clinical manifestation of glaucomatous damage needs to be determined within longitudinal studies of compliant and stiff eyes of all ages that have been matched for similar levels of cumulative IOP exposure and glaucomatous damage. 

In summary, the results of this cross-sectional study are consistent with the concept that glaucomatous structure/structure and structure/function relationships change with age. In younger eyes, laminar position was deeper in eyes with more pronounced VF loss, whereas in older eyes, laminar position was independent of VF MD. 

Acknowledgments

The authors thank Juan Reynaud, Cindy Blachly, and Michael Whitworth for their SDOCT technical support (JR) and clinical imaging of the P3 participants (CB and MW). We also thank Joanne Couchman for assistance with manuscript preparation and submission. 

Presented in part at the annual meeting of the American Glaucoma Society, New York, New York, March 2012, and at the Annual Meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2012. 

Supported by National Institutes of Health (NIH)/National Eye Institute (NEI) Grant R01-EY-019674 (SD); Legacy Good Samaritan Foundation; Carl Zeiss Meditec; NIH/NEI Grant R01-EY021281 (CFB); and Heidelberg Engineering, GmbH, Heidelberg, Germany. Claude F. Burgoyne is a consultant to Heidelberg Engineering. The above listed sponsors/funding organizations had no role in the design or conduct of this research. The authors alone are responsible for the content and writing of the paper. 

Disclosure: R. Ren, None; H. Yang, None; S.K. Gardiner, None; B. Fortune, Carl Zeiss Meditec (F), Heidelberg Engineering (F); C. Hardin, None; S. Demirel, Legacy Good Samaritan Foundation (F), Carl Zeiss Meditec (F); C.F. Burgoyne, Legacy Good Samaritan Foundation (F), Heidelberg Engineering (F, C, R) 

Footnotes

 RR and HY contributed equally to the work and should therefore be regarded as equivalent authors.